©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1804-1816
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1804
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1804
Table 1 Patient characteristics, comorbidities in hereditary hemochromatosis (excluding liver diseases) patients
| Variables | Weighted, n | Weighted, % (95%Cl) |
| Total, n | 18031 | |
| Sex | ||
| Female | 6903 | 38.27 (36.59–39.9) |
| Male | 11123 | 61.69 (59.9–63.4) |
| Age (y), mean (SD) | 62.19 ± 34.36 | |
| Age groups (yr) | ||
| < 18 | 158 | 0.88 (0.54–1.20) |
| 18-44 | 2046 | 11.37 (10.2–12.5) |
| 45-64 | 7007 | 38.90 (37.15–40.6) |
| 65-84 | 7933 | 43.93 (42.2–45.7) |
| 85+ | 887 | 4.91 (4.15–5.69) |
| Race/Ethnicity | ||
| White | 15850 | 87.87 (86.6–89.2) |
| Black | 315 | 1.76 (1.30–2.19) |
| Hispanic | 545 | 3.01 (2.42–3.62) |
| Asian or Pacific Islander | 105 | 0.58 (0.33–0.83) |
| Native American | 30 | 0.17 (0.03–0.30) |
| Other | 1186 | 6.60 (5.52–7.63) |
| Comorbidities | ||
| Coronary artery disease | 3357 | 18.61 (17.24–20.0) |
| Cardiomyopathy | 900 | 4.99 (4.19–5.79) |
| Arrythmias | 4250 | 23.57 (22.1–25.1) |
| Heart failure | 2848 | 15.79 (14.5–17.1) |
| Liver cancer | 209 | 1.16 (0.78–1.53) |
| HIV | 35 | 0.19 (0.05–0.34) |
| Alpha1-antitrypsin deficiency | 55 | 0.31 (0.11–0.49) |
| Disorders of porphyrin metabolism | 105 | 0.58 (0.30–0.86) |
| Hepatomegaly | 123 | 0.68 (0.38–0.98) |
| Splenomegaly | 169 | 0.93 (0.56–1.32) |
| Hypertension | 7892 | 43.76 (42.0–45.5) |
| Diabetes mellitus with chronic complications | 2323 | 12.88 (11.7–14.1) |
| Diabetes mellitus without chronic complications | 2485 | 13.78 (12.6–15.0) |
| Lipid metabolism disorders | 6781 | 37.60 (35.9–39.3) |
| Thyroid disorders | 3285 | 18.21 (16.9–15.6) |
| Pancreatitis | 484 | 2.69 (2.13–3.23) |
| Pituitary disorders | 259 | 1.43 (0.99–1.87) |
| Obesity | 2971 | 16.48 (15.1–17.9) |
| Depression | 2673 | 14.82 (13.5–16.1) |
| Symptoms | ||
| Musculoskeletal pain | 1011 | 5.61 (4.79–6.42) |
| Malaise and fatigue | 557 | 3.09 (2.49–3.68) |
| Arthropathy | 384 | 2.13 (1.65–2.61) |
| Weight Loss | 219 | 1.22 (0.81–1.61) |
| Loss of appetite | 87 | 0.49 (0.26–0.70) |
| Hypogonadism | 193 | 1.07 (0.66–1.49) |
| Erectile dysfunction | 140 | 0.78 (0.45–1.10) |
| jaundice | 184 | 1.02 (0.67–1.38) |
| Disorientation | 374 | 2.07 (1.61–2.54) |
| Family history | ||
| Family history of diseases of the circulatory system | 1109 | 6.15 (5.26–7.04) |
| Family history of diabetes mellitus | 500 | 2.77 (2.17–3.37) |
| Family history of malignant neoplasms | 814 | 4.51 (3.77–5.25) |
| Substance use | ||
| Smoking | 7577 | 42.02 (40.2–43.8) |
| Alcohol | 1536 | 8.52 (7.49–9.54) |
| Cannabis use | 219 | 1.22 (0.83–1.60) |
| Opioids | 315 | 1.74 (1.29–2.20) |
- Citation: Haider MB, Al Sbihi A, Chaudhary AJ, Haider SM, Edhi AI. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study. World J Hepatol 2022; 14(9): 1804-1816
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1804.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1804